Massive RSV vaccine trial aims to keep adults out of the hospital
⭐️ VACCINE ⭐️
Recruiting now
This large study is testing whether the Abrysvo RSV vaccine can prevent adults from being hospitalized due to RSV. About 690,000 adults aged 18 and older will be randomly assigned to receive either the vaccine or no vaccine. The main goal is to see if the vaccine reduces RSV-rela…
Phase: PHASE4 • Sponsor: Tor Biering-Sørensen • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 29, 2026 05:02 UTC